Chularat Hospital Public Company (CHG) Fair Value & Analysis
Healthcare · TH · Market cap 17.9B THB
Fair value as of: Jul 19, 2026
From 26 valuation models · updated 22 days ago
Share price +5.8% over the past month.
A solid business, screening 13% undervalued on our models.
What matters now
- Our model range runs from 1.38 THB (bear) to 2.32 THB (bull), base 1.86 THB. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 70/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
60‑month range 1.31 THB – 3.53 THB · fair‑value band 1.38 THB – 2.32 THB · the 1.65 THB price screens below the 1.86 THB fair value. Dashed = 300-day average. As of Jul 19, 2026.
Analysis
Chularat Hospital Public Company (CHG) currently trades at 1.65 THB, while our model-based Fair Value estimate is 1.86 THB, implying the stock looks roughly 12.7% undervalued today. The Quality Score stands at 70/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Chularat Hospital Public Company generated revenue of 8.5B THB at a net margin of 11.2%. Revenue grew 4.5% year over year. It earns a return on equity of 11.7%. The balance sheet holds a net cash position of 1.2B THB. Fundamentals as of Jul 19, 2026
Our scenario range runs from 1.38 THB (bear case) to 2.32 THB (bull case); at 1.65 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 7% below its 52-week high and 26% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 13%, CHG screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (2.04 THB) versus Asset-Based (0.4800 THB). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 62
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Chularat Hospital Public Company Limited, together with its subsidiaries, operates clinics and hospitals in Thailand. The company also provides a comprehensive health screening center. In addition, it sells medicine and medical supplies. Chularat Hospital Public Company Limited was founded in 1986 and is headquartered in Samut Prakan, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Chularat Hospital Public Company reported revenue of 8.3B THB in FY2025 versus 11.7B THB in FY2021, a compound −8.2%/yr. Reported net income was 929M THB in FY2025, compounding −31.4%/yr from FY2021.
Watch CHG: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Chularat Hospital Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Chularat Hospital Public Company (CHG) overvalued or undervalued?
What is the fair value of CHG?
What is the quality score of CHG?
What is the revenue of Chularat Hospital Public Company (CHG)?
What is the net profit margin of CHG?
Does Chularat Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Chularat Hospital Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.